CSIMarket
 


Regenerx Biopharmaceuticals inc   (RGRX)
Other Ticker:  
 
 

RGRX's Net Cash Flow Growth by Quarter and Year

Regenerx Biopharmaceuticals Inc 's Net Cash Flow results by quarter and year




RGRX Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -0.19 -0.29 0.29
III Quarter September - -0.23 -0.50 -0.24
II Quarter June - -0.22 1.82 -0.24
I Quarter March -0.19 -0.31 -0.22 -0.03
FY   -0.19 -0.95 0.81 -0.22



RGRX Net Cash Flow first quarter 2023 Y/Y Growth Comment
Regenerx Biopharmaceuticals inc in the first quarter 2023 recorded net cash outflow of $ -0.19 millions.

According to the results reported in the first quarter 2023, Regenerx Biopharmaceuticals Inc achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Regenerx Biopharmaceuticals Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the first quarter 2023.




RGRX Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -27.5 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Regenerx Biopharmaceuticals Inc 's first quarter 2023 Net Cash Flow $ -0.19 millions RGRX's Income Statement
Regenerx Biopharmaceuticals Inc 's first quarter 2022 Net Cash Flow $ -0.31 millions Quarterly RGRX's Income Statement
New: More RGRX's historic Net Cash Flow Growth >>


RGRX Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Regenerx Biopharmaceuticals Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RGRX's I. Quarter Q/Q Net Cash Flow Comment
Recent results of -0.19 millions by Regenerx Biopharmaceuticals inc look even worse compare to the -0.19 millions net cash outflow in the previous quarter.

Within Major Pharmaceutical Preparations industry Regenerx Biopharmaceuticals inc achieved highest sequential Net Cash Flow growth. While Regenerx Biopharmaceuticals Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RGRX's I. Quarter Q/Q Net Cash Flow Comment
Current accomplishment of -0.19 millions by Regenerx Biopharmaceuticals inc appear even more unfavourable compare to the net cash outflow -0.19 millions a quarter before.

Within Major Pharmaceutical Preparations industry Regenerx Biopharmaceuticals inc achieved highest sequential Net Cash Flow growth. While Regenerx Biopharmaceuticals Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Regenerx Biopharmaceuticals Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ -0.82 $ -0.94 $ -1.04 $ -1.32 $ 0.72
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -10.7 %
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 295 # 428 # 396 # 0 # 368




Cumulative Net Cash Flow growth Comment
Regenerx Biopharmaceuticals Inc realized trailing twelve months net cash outflow of $ -1 millions, in the Mar 31 2023, compare to Net Cash Flow of $ 1 millions a year ago.

Regenerx Biopharmaceuticals inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
8.93 %
-191.64 %
-316.64 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 48
S&P 500 # 295
Cumulative Net Cash Flow growth Comment
Regenerx Biopharmaceuticals Inc realized trailing twelve months net cash outflow of $ -1 millions, in the Mar 31 2023, compare to Net Cash Flow of $ 1 millions a year ago.

Regenerx Biopharmaceuticals inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
8.93 %
-191.64 %
-316.64 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 22
Sector # 48
S&P 500 # 295




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
RGRX's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for RGRX's Competitors
Net Cash Flow Growth for Regenerx Biopharmaceuticals Inc 's Suppliers
Net Cash Flow Growth for RGRX's Customers

You may also want to know
RGRX's Annual Growth Rates RGRX's Profitability Ratios RGRX's Asset Turnover Ratio RGRX's Dividend Growth
RGRX's Roe RGRX's Valuation Ratios RGRX's Financial Strength Ratios RGRX's Dividend Payout Ratio
RGRX's Roa RGRX's Inventory Turnover Ratio RGRX's Growth Rates RGRX's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Mar 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2023
Avadel Pharmaceuticals Plc-7.43%$ -7.427 millions
Verastem inc -9.73%$ -9.731 millions
Airsculpt Technologies Inc -11.42%$ -11.424 millions
International Stem Cell Corporation-11.45%$ -11.454 millions
Solid Biosciences Inc -12.39%$ -12.388 millions
2seventy Bio Inc -12.78%$ -12.778 millions
Amylyx Pharmaceuticals Inc -13.91%$ -13.906 millions
Rapt Therapeutics Inc -18.70%$ -18.699 millions
Inotiv Inc -19.20%$ -19.198 millions
Harvard Apparatus Regenerative Technology Inc -20.03%$ -20.032 millions
Verrica Pharmaceuticals Inc -25.90%$ -25.901 millions
Aileron Therapeutics Inc -32.74%$ -32.736 millions
Edwards Lifesciences Corporation-38.18%$ -38.177 millions
Vapotherm Inc -40.24%$ -40.241 millions
Tenon Medical Inc -40.34%$ -40.341 millions
Amedisys Inc -40.47%$ -40.465 millions
Lipocine Inc -41.76%$ -41.758 millions
Satsuma Pharmaceuticals Inc -43.94%$ -43.936 millions
Earth Science Tech Inc -49.87%$ -49.871 millions
Acer Therapeutics Inc -49.93%$ -49.926 millions
Intelgenx Technologies Corp -50.66%$ -50.658 millions
China Health Industries Holdings Inc -51.25%$ -51.248 millions
H cyte Inc-52.86%$ -52.863 millions
Amphastar Pharmaceuticals Inc -55.66%$ -55.662 millions
Infusystem Holdings Inc-58.45%$ -58.447 millions
Siga Technologies Inc-66.30%$ -66.301 millions
Bolt Biotherapeutics Inc -66.39%$ -66.390 millions
Alector Inc -67.14%$ -67.137 millions
Revance Therapeutics Inc -67.18%$ -67.181 millions
Altair International Corp -71.61%$ -71.610 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com